Cargando…

Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study

BACKGROUNDS: Periprocedural myocardial injury (PMI) after elective percutaneous coronary intervention (PCI) significantly influences the prognosis of coronary artery disease (CAD). However, it was unclear whether the occurrence of PMI was associated with a series of controllable factors, such as PCI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhang-Wei, Yang, Hong-Bo, Chen, Ying-Hua, Ma, Jian-Ying, Qian, Ju-Ying, Ge, Jun-Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327562/ https://www.ncbi.nlm.nih.gov/pubmed/28241795 http://dx.doi.org/10.1186/s12872-017-0501-x

Ejemplares similares

Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention
por: Zhou, You, et al.
Publicado: (2021)

Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions – is there an association?
por: Stipinovic, Mario, et al.
Publicado: (2019)

Elevated serum miR-133a predicts patients at risk of periprocedural myocardial injury after elective percutaneous coronary intervention
por: Zhou, You, et al.
Publicado: (2022)

Association between serum angiopoietin-2 concentrations and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Jian, Wen, et al.
Publicado: (2020)

Association between NLRP3 inflammasome and periprocedural myocardial injury following elective PCI
por: Chen, Ao, et al.
Publicado: (2023)

Predictors and Periprocedural Myocardial Injury Rate of Small Side Branches Occlusion in Coronary Bifurcation Intervention
por: Zhang, Dong, et al.
Publicado: (2015)

Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Yin, Yun-jie, et al.
Publicado: (2020)

Periprocedural Hemoglobin Changes and Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
por: Alizadeh, Keivan, et al.
Publicado: (2013)

Peripheral Artery Tonometry Reveals Impaired Endothelial Function before Percutaneous Coronary Intervention in Patients with Periprocedural Myocardial Injury
por: Chen, Zhangwei, et al.
Publicado: (2021)

Impact of high-density lipoprotein 3 cholesterol subfraction on periprocedural myocardial injury in patients who underwent elective percutaneous coronary intervention
por: Harada, Kazuhiro, et al.
Publicado: (2018)

LDL-C and Total Stent Length are Independent Predictors of Periprocedural Myocardial Injury and Infarction for Unstable Angina Patients Undergoing Elective Percutaneous Coronary Intervention
por: Chen, Xuefeng, et al.
Publicado: (2021)

Clinical Characteristics and Risk Factors of Periprocedural Myocardial Injury in Patients with Elective PCI in a TCM Hospital
por: Li, Xiang, et al.
Publicado: (2022)

Validation of a Novel Clinical Prediction Score for Severe Coronary Artery Diseases before Elective Coronary Angiography
por: Chen, Zhang-Wei, et al.
Publicado: (2014)

Coronary plaque morphology on multi-modality imagining and periprocedural myocardial infarction after percutaneous coronary intervention()
por: Sato, Akira, et al.
Publicado: (2016)

Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China
por: Zhong, Zhixiong, et al.
Publicado: (2018)

Elective percutaneous coronary intervention leads to significant changes in serum resistin, leptin, and adiponectin levels regardless of periprocedural myocardial injury: an observational study
por: Buturak, Ali, et al.
Publicado: (2016)

Impact of increased inflammation biomarkers on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention: a cohort study
por: Zhao, Liding, et al.
Publicado: (2020)

Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention
por: Huang, Zhuoshan, et al.
Publicado: (2020)

Periprocedural myocardial injury in the EXCEL trial
por: Bjørnstad, Johannes L, et al.
Publicado: (2020)

Development of Multi-Vessel Coronary No-Reflow Following Elective Percutaneous Intervention in One Vessel
por: Hussain, Syed W, et al.
Publicado: (2023)

Relationship of High‐Density Lipoprotein Cholesterol With Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention in Patients With Low‐Density Lipoprotein Cholesterol Below 70 mg/dL
por: Li, Xiao‐Lin, et al.
Publicado: (2015)

Three-dimensional assessment of coronary high-intensity plaques with T1-weighted cardiovascular magnetic resonance imaging to predict periprocedural myocardial injury after elective percutaneous coronary intervention
por: Hosoda, Hayato, et al.
Publicado: (2020)

Predictive Value of Aortic Valve Calcification for Periprocedural Myocardial Injury in Patients Undergoing Percutaneous Coronary Intervention
por: Shibata, Yohei, et al.
Publicado: (2017)

Influence of Stent Length on Periprocedural Outcomes After Primary Percutaneous Coronary Intervention in Patients with ST Segment Elevation Myocardial Infarction
por: Chen, Yan, et al.
Publicado: (2022)

Correction to: Three-dimensional assessment of coronary high-intensity plaques with T1-weighted cardiovascular magnetic resonance imaging to predict periprocedural myocardial injury after elective percutaneous coronary intervention
por: Hosoda, Hayato, et al.
Publicado: (2020)

COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): Coronary Microvascular Physiology Pilot Substudy
por: Cole, Justin, et al.
Publicado: (2022)

Effects of Shen-Yuan-Dan on Periprocedural Myocardial Injury and the Number of Peripheral Blood Endothelial Progenitor Cells in Patients with Unstable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention
por: Zhang, Zhenmin, et al.
Publicado: (2022)

Frequency and outcomes of periprocedural myocardial infarction in patients with chronic coronary syndromes undergoing percutaneous coronary intervention
por: Ueki, Yasushi, et al.
Publicado: (2022)

Positive Association of Coronary Calcium Detected by Computed Tomography Coronary Angiography with Periprocedural Myocardial Infarction
por: Wang, Xinguo, et al.
Publicado: (2013)

Periprocedural temporary pacing in primary percutaneous coronary intervention for patients with acute inferior myocardial infarction
por: Hwang, You Mi, et al.
Publicado: (2016)

Prognostic Impact of Percutaneous Coronary Intervention of Chronic Total Occlusion in Acute and Periprocedural Myocardial Infarction
por: Kim, Seung-Hyun, et al.
Publicado: (2021)

Activities of daily living predict periprocedural myocardial infarction and injury following percutaneous coronary intervention: a cross-sectional study
por: Pan, Yifan, et al.
Publicado: (2023)

Postdischarge prognostic significance of periprocedural myocardial injury after percutaneous intervention of chronic total occlusion
por: Poels, Ella, et al.
Publicado: (2022)

Impact of periprocedural myocardial injury on long-term clinical outcomes of chronic total occlusion patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
por: Liu, Mei-Jun, et al.
Publicado: (2020)

Association of chronic kidney disease with periprocedural myocardial injury after elective stent implantation: A single center prospective cohort study
por: Jerkic, Helena, et al.
Publicado: (2016)

Factors associated with periprocedural myocardial infarction
por: Okşul, Metin, et al.
Publicado: (2019)

Prognostic implications of unrecognized myocardial infarction and periprocedural myocardial injury on cardiac magnetic resonance imaging in patients with chronic coronary syndrome
por: Kanaji, Yoshihisa, et al.
Publicado: (2023)

High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: A meta-analysis of fifteen randomized controlled trials
por: Liu, Jiahui, et al.
Publicado: (2021)

Risk Factors of Periprocedural Bradycardia during Primary Percutaneous Coronary Intervention in Patients with Acute ST-Elevation Myocardial Infarction
por: Li, Yong, et al.
Publicado: (2019)

High-Dose Statin Pretreatment Decreases Periprocedural Myocardial Infarction and Cardiovascular Events in Patients Undergoing Elective Percutaneous Coronary Intervention: A Meta-Analysis of Twenty-Four Randomized Controlled Trials
por: Wang, Le, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_34e7au62fkkgbu39jfviug0okj